^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    TBI 1201

    i
    Other names: TBI 1201, MAGE-A4 antigen-specific TCR modified lymphocytes, MAGE-A4 antigen-specific RetroNectin TCR gene therapy, MAGE-A4 TCR-transduced T-cell therapy, TBI-1201
    Associations
    News
    Trials
    Company:
    Takara
    Drug class:
    TCR modulator, MAGE-A4 inhibitor
    Related drugs:
    Associations
    News
    Trials